In addition, introducing the fibroblast growth factor receptor 1 (FGFR1) inhibitor NSC12 could reverse the effect of FGF2 in DRG cells and reduce the pain hyperalgesia of endometriosis rats. The gene discussed is FGF2; the disease is endometriosis.